Reuters logo
BRIEF-CSL receives US FDA approval of privigen for CIDP indication
September 15, 2017 / 12:17 AM / 2 months ago

BRIEF-CSL receives US FDA approval of privigen for CIDP indication

Sept 15 (Reuters) - Csl Ltd

* FDA approves privigen for cidp indication

* Has approved CSL Behring’s Privigen for treatment of adults with chronic inflammatory demyelinating polyneuropathy to improve neuromuscular disability Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below